PGP and ovarian carcinoma: In conclusion, the present study demonstrated that miR-21 may regulate the expression of MDR1/P-gp, at least in part, by targeting HIF-1α, which is involved in the development of drug resistance in paclitaxel-resistant ovarian cancer A2780/taxol cell lines.